186 related articles for article (PubMed ID: 27596438)
1. ZEB1-mediated melanoma cell plasticity enhances resistance to MAPK inhibitors.
Richard G; Dalle S; Monet MA; Ligier M; Boespflug A; Pommier RM; de la Fouchardière A; Perier-Muzet M; Depaepe L; Barnault R; Tondeur G; Ansieau S; Thomas E; Bertolotto C; Ballotti R; Mourah S; Battistella M; Lebbé C; Thomas L; Puisieux A; Caramel J
EMBO Mol Med; 2016 Oct; 8(10):1143-1161. PubMed ID: 27596438
[TBL] [Abstract][Full Text] [Related]
2. ZEB1 controls a lineage-specific transcriptional program essential for melanoma cell state transitions.
Durand S; Tang Y; Pommier RM; Benboubker V; Grimont M; Boivin F; Barbollat-Boutrand L; Cumunel E; Dupeuble F; Eberhardt A; Plaschka M; Dalle S; Caramel J
Oncogene; 2024 May; 43(20):1489-1505. PubMed ID: 38519642
[TBL] [Abstract][Full Text] [Related]
3. Combinatorial Treatment with PARP and MAPK Inhibitors Overcomes Phenotype Switch-Driven Drug Resistance in Advanced Melanoma.
Ferretti LP; Böhi F; Leslie Pedrioli DM; Cheng PF; Ferrari E; Baumgaertner P; Alvarado-Diaz A; Sella F; Cereghetti A; Turko P; Wright RH; De Bock K; Speiser DE; Ferrari R; Levesque MP; Hottiger MO
Cancer Res; 2023 Dec; 83(23):3974-3988. PubMed ID: 37729428
[TBL] [Abstract][Full Text] [Related]
4. Tracking the EMT-like phenotype switching during targeted therapy in melanoma by analyzing extracellular vesicle phenotypes.
Zhou Q; Wang J; Zhang Z; Wuethrich A; Lobb RJ; Trau M
Biosens Bioelectron; 2024 Jan; 244():115819. PubMed ID: 37952322
[TBL] [Abstract][Full Text] [Related]
5. SOX10 deficiency-mediated LAMB3 upregulation determines the invasiveness of MAPKi-resistant melanoma.
Han S; Zhang M; Qu X; Wu Z; Huang Z; Hu Y; Li Y; Cui L; Si L; Liu J; Shao Y
Oncogene; 2024 Feb; 43(6):434-446. PubMed ID: 38102338
[TBL] [Abstract][Full Text] [Related]
6. Connecting the dots: Melanoma cell of origin, tumor cell plasticity, trans-differentiation, and drug resistance.
Castro-Pérez E; Singh M; Sadangi S; Mela-Sánchez C; Setaluri V
Pigment Cell Melanoma Res; 2023 Sep; 36(5):330-347. PubMed ID: 37132530
[TBL] [Abstract][Full Text] [Related]
7. Sustained compensatory p38 MAPK signaling following treatment with MAPK inhibitors induces the immunosuppressive protein CD73 in cancer: combined targeting could improve outcomes.
Terp MG; Gammelgaard OL; Vever H; Gjerstorff MF; Ditzel HJ
Mol Oncol; 2021 Dec; 15(12):3299-3316. PubMed ID: 34165921
[TBL] [Abstract][Full Text] [Related]
8. Blocking Genomic Instability Prevents Acquired Resistance to MAPK Inhibitor Therapy in Melanoma.
Dharanipragada P; Zhang X; Liu S; Lomeli SH; Hong A; Wang Y; Yang Z; Lo KZ; Vega-Crespo A; Ribas A; Moschos SJ; Moriceau G; Lo RS
Cancer Discov; 2023 Apr; 13(4):880-909. PubMed ID: 36700848
[TBL] [Abstract][Full Text] [Related]
9. Melanoma plasticity and phenotypic diversity: therapeutic barriers and opportunities.
Rambow F; Marine JC; Goding CR
Genes Dev; 2019 Oct; 33(19-20):1295-1318. PubMed ID: 31575676
[TBL] [Abstract][Full Text] [Related]
10. Microenvironment-Driven Dynamic Heterogeneity and Phenotypic Plasticity as a Mechanism of Melanoma Therapy Resistance.
Ahmed F; Haass NK
Front Oncol; 2018; 8():173. PubMed ID: 29881716
[TBL] [Abstract][Full Text] [Related]
11. RhoA activation promotes glucose uptake to elevate proliferation in MAPK inhibitor resistant melanoma cells.
Murali VS; Rajendran D; Isogai T; DeBerardinis RJ; Danuser G
bioRxiv; 2024 Jan; ():. PubMed ID: 38260449
[TBL] [Abstract][Full Text] [Related]
12. Drug-Tolerant Idling Melanoma Cells Exhibit Theory-Predicted Metabolic Low-Low Phenotype.
Jia D; Paudel BB; Hayford CE; Hardeman KN; Levine H; Onuchic JN; Quaranta V
Front Oncol; 2020; 10():1426. PubMed ID: 32923395
[TBL] [Abstract][Full Text] [Related]
13. Cancer Cell Biomechanical Properties Accompany Tspan8-Dependent Cutaneous Melanoma Invasion.
Runel G; Lopez-Ramirez N; Barbollat-Boutrand L; Cario M; Durand S; Grimont M; Schartl M; Dalle S; Caramel J; Chlasta J; Masse I
Cancers (Basel); 2024 Feb; 16(4):. PubMed ID: 38398085
[TBL] [Abstract][Full Text] [Related]
14. Rebound growth of BRAF mutant pediatric glioma cells after MAPKi withdrawal is associated with MAPK reactivation and secretion of microglia-recruiting cytokines.
Kocher D; Cao L; Guiho R; Langhammer M; Lai YL; Becker P; Hamdi H; Friedel D; Selt F; Vonhören D; Zaman J; Valinciute G; Herter S; Picard D; Rettenmeier J; Maass KK; Pajtler KW; Remke M; von Deimling A; Pusch S; Pfister SM; Oehme I; Jones DTW; Halbach S; Brummer T; Martinez-Barbera JP; Witt O; Milde T; Sigaud R
J Neurooncol; 2024 Apr; ():. PubMed ID: 38630384
[TBL] [Abstract][Full Text] [Related]
15. EMT-Inducing Transcription Factors, Drivers of Melanoma Phenotype Switching, and Resistance to Treatment.
Tang Y; Durand S; Dalle S; Caramel J
Cancers (Basel); 2020 Aug; 12(8):. PubMed ID: 32759677
[TBL] [Abstract][Full Text] [Related]
16. Transition Therapy: Tackling the Ecology of Tumor Phenotypic Plasticity.
Aguadé-Gorgorió G; Kauffman S; Solé R
Bull Math Biol; 2021 Dec; 84(1):24. PubMed ID: 34958403
[TBL] [Abstract][Full Text] [Related]
17. Cross-Talk Between circRNAs and mRNAs Modulates MiRNA-mediated Circuits and Affects Melanoma Plasticity.
Fumagalli MR; Lionetti MC; Zapperi S; La Porta CAM
Cancer Microenviron; 2019 Dec; 12(2-3):95-104. PubMed ID: 31734859
[TBL] [Abstract][Full Text] [Related]
18. Systematic screening reveals synergistic interactions that overcome MAPK inhibitor resistance in cancer cells.
Yu Y; Tao M; Xu L; Cao L; Le B; An N; Dong J; Xu Y; Yang B; Li W; Liu B; Wu Q; Lu Y; Xie Z; Lian X
Cancer Biol Med; 2021 Jun; 19(2):229-52. PubMed ID: 34106558
[TBL] [Abstract][Full Text] [Related]
19. Metabolism-dependent secondary effect of anti-MAPK cancer therapy on DNA repair.
Aubé F; Fontrodona N; Guiguettaz L; Vallin E; Fabbri L; Lapendry A; Vagner S; Ricci EP; Auboeuf D
NAR Cancer; 2024 Jun; 6(2):zcae019. PubMed ID: 38690580
[TBL] [Abstract][Full Text] [Related]
20. JUN dependency in distinct early and late BRAF inhibition adaptation states of melanoma.
Titz B; Lomova A; Le A; Hugo W; Kong X; Ten Hoeve J; Friedman M; Shi H; Moriceau G; Song C; Hong A; Atefi M; Li R; Komisopoulou E; Ribas A; Lo RS; Graeber TG
Cell Discov; 2016; 2():16028. PubMed ID: 27648299
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
